Company ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Equities
1541
CNE100006624
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
13.92 HKD | -0.57% |
|
-1.69% | -53.44% |
06-24 | ImmuneOnco Biopharmaceuticals Gets IND Approval for NMOSDs Drug Trial in China | MT |
06-03 | ImmuneOnco Biopharmaceuticals Gets China's Phase 3 Trial Approval for Leukemia Drug | MT |
Business Summary
Number of employees: 145
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cell Strain and Other Products
95.1
%
| 1 | 92.8 % | 0 | 95.1 % | -30.11% |
Testing Services
4.9
%
| 0 | 7.2 % | 0 | 4.9 % | -53.71% |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -31.82% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wen Zhi Tian
CEO | Chief Executive Officer | - | 15-05-31 |
Qi Ying Lu
CTO | Chief Tech/Sci/R&D Officer | - | 22-02-28 |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 15-11-30 |
Zikai Xiong
PRN | Corporate Officer/Principal | - | 22-02-28 |
Ru liang Zhang
PRN | Corporate Officer/Principal | - | 17-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chi Tat Yeung
BRD | Director/Board Member | 55 | 22-05-31 |
Zhi Hua Yu
BRD | Director/Board Member | 57 | - |
Wen Zhi Tian
CEO | Chief Executive Officer | - | 15-05-31 |
Zhenping Zhu
BRD | Director/Board Member | - | - |
Xiao Yong Yu
BRD | Director/Board Member | 51 | - |
Song Li
CTO | Chief Tech/Sci/R&D Officer | - | 15-11-30 |
Cong Xu
BRD | Director/Board Member | - | - |
Kendall Smith
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 374,157,695 | 69,612,628 ( 18.61 %) | 0 | 18.61 % |
Company contact information
ImmuneOnco Biopharmaceuticals (Shanghai) Co., Ltd.
Building 15, Lane 1000 Zhangheng Road
200120, Zhangjiang Science City
+86 21 3801 6387
http://cn.immuneonco.com![address ImmuneOnco Biopharmaceuticals (Shanghai) Inc.(1541)](https://cdn.zonebourse.com/static/address/158607346.png)
Sector
Sales per Business
![Consensus](/images/consensus_flch.gif)
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.44% | 671M | |
+16.45% | 122B | |
+21.96% | 116B | |
+23.73% | 27.03B | |
-20.05% | 20.36B | |
-16.28% | 15.91B | |
-16.52% | 16.43B | |
-44.35% | 15.6B | |
+63.91% | 14.94B | |
+2.52% | 13.59B |
- Stock Market
- Equities
- 1541 Stock
- Company ImmuneOnco Biopharmaceuticals (Shanghai) Inc.